Skip to main navigation Skip to search Skip to main content

A phase 3 open label extension of COURAGE-ALS (CY 5031)

Project: Research

Project Details

StatusFinished
Effective start/end date10/20/22 → 10/19/24

Funding

  • Cytokinetics Incorporated: $59,763.70